azoxymethane has been researched along with ibuprofen in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aligia, C; Kelloff, G; Kulkarni, N; Reddy, BS; Tokumo, K | 1 |
| Chen, CD; Harris, C; Velasco, M; Wargovich, MJ; Yang, E | 1 |
| Ji, P; Ouyang, N; Williams, JL | 1 |
3 other study(ies) available for azoxymethane and ibuprofen
| Article | Year |
|---|---|
Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds.
Topics: Animals; Azoxymethane; Colonic Neoplasms; Glycyrrhetinic Acid; Ibuprofen; Ketoprofen; Male; Piroxicam; Random Allocation; Rats; Rats, Inbred F344 | 1992 |
Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon.
Topics: Acetaminophen; Adenoma; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Azoxymethane; Colonic Neoplasms; Drug Screening Assays, Antitumor; Fenretinide; Ibuprofen; Isotretinoin; Male; Piroxicam; Precancerous Conditions; Rats; Rats, Inbred F344 | 1995 |
A novel NSAID derivative, phospho-ibuprofen, prevents AOM-induced colon cancer in rats.
Topics: Aberrant Crypt Foci; Animals; Anticarcinogenic Agents; Azoxymethane; beta Catenin; Carcinogens; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Ibuprofen; Neoplasms, Experimental; NF-kappa B; Organophosphates; Rats | 2013 |